Richard Francis's most recent trade in Netsol Technologies, Inc. was a trade of 5,476 Common Stock done . Disclosure was reported to the exchange on July 9, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Netsol Technologies, Inc. | Michael Richard Francis | Director | 09 Jul 2025 | 5,476 | 20,401 (0%) | 0% | 0 | Common Stock | ||
| Netsol Technologies, Inc. | Michael Richard Francis | Director | 09 Jul 2025 | 4,261 | 24,662 (0%) | 0% | 0 | Common Stock | ||
| Teva- Pharmaceutical Indus... | Richard D. Francis | President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 52,173 | 52,173 | - | - | Restricted Share Units | |
| Teva- Pharmaceutical Indus... | Richard D. Francis | President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2025 | 169,811 | 169,811 | - | - | Restricted Share Units | |
| Teva- Pharmaceutical Indus... | Richard D. Francis | President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 50,223 | 295,556 (0%) | 0% | - | Ordinary Shares | |
| Teva- Pharmaceutical Indus... | Richard D. Francis | President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 50,223 | 150,669 | - | - | Restricted Share Units | |
| Teva- Pharmaceutical Indus... | Richard D. Francis | President and CEO | Sale of securities on an exchange or to another person at price $ 15.73 per share. | 04 Mar 2025 | 15,514 | 280,042 (0%) | 0% | 15.7 | 244,107 | Ordinary Shares |
| Teva- Pharmaceutical Indus... | Richard D. Francis | President and CEO | Sale of securities on an exchange or to another person at price $ 15.91 per share. | 04 Mar 2025 | 8,259 | 271,783 (0%) | 0% | 15.9 | 131,427 | Ordinary Shares |
| Teva- Pharmaceutical Indus... | Richard D. Francis | President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 67,231 | 276,675 (0%) | 0% | - | Ordinary Shares | |
| Teva- Pharmaceutical Indus... | Richard D. Francis | President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 67,231 | 134,462 | - | - | Restricted Share Units | |
| Teva- Pharmaceutical Indus... | Richard D. Francis | President and CEO | Sale of securities on an exchange or to another person at price $ 16.19 per share. | 03 Mar 2025 | 24,892 | 251,783 (0%) | 0% | 16.2 | 402,889 | Ordinary Shares |
| Teva- Pharmaceutical Indus... | Richard D. Francis | President and CEO | Sale of securities on an exchange or to another person at price $ 15.56 per share. | 03 Mar 2025 | 6,450 | 245,333 (0%) | 0% | 15.6 | 100,347 | Ordinary Shares |
| Teva- Pharmaceutical Indus... | Richard D. Francis | President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2025 | 161,655 | 284,950 (0%) | 0% | - | Ordinary Shares | |
| Teva- Pharmaceutical Indus... | Richard D. Francis | President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2025 | 161,655 | 161,656 | - | - | Restricted Share Units | |
| Teva- Pharmaceutical Indus... | Richard D. Francis | President and CEO | Sale of securities on an exchange or to another person at price $ 16.95 per share. | 15 Feb 2025 | 75,506 | 209,444 (0%) | 0% | 16.9 | 1,279,661 | Ordinary Shares |
| Netsol Technologies, Inc. | Michael Richard Francis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 5,058 | 14,925 (0%) | 0% | 0 | Common Stock | |
| Mettler-Toledo International | Richard D. Francis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2024 | 182 | 182 | - | - | Stock Option (right to buy) | |
| Mettler-Toledo International | Richard D. Francis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2024 | 71 | 624 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Netsol Technologies, Inc. | Michael Richard Francis | Director | 01 Oct 2024 | 4,650 | 9,867 (0%) | 0% | 0 | Common Stock | ||
| Netsol Technologies, Inc. | Michael Richard Francis | Director | 01 Jul 2024 | 5,217 | 5,217 (0%) | 0% | 0 | Common Stock | ||
| Netsol Technologies, Inc. | Michael Richard Francis | Director | 20 Jun 2024 | 9,559 | 0 (0%) | 0% | 2.5 | 24,184 | Common Stock | |
| Netsol Technologies, Inc. | Michael Richard Francis | Director | 20 Jun 2024 | 8,569 | 9,559 (0%) | 0% | 2.6 | 22,194 | Common Stock | |
| Netsol Technologies, Inc. | Michael Richard Francis | Director | 02 Apr 2024 | 4,784 | 18,128 (0%) | 0% | 0 | Common Stock | ||
| Teva- Pharmaceutical Indus... | Richard D. Francis | President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2024 | 200,892 | 200,892 | - | - | Restricted Share Units | |
| Teva- Pharmaceutical Indus... | Richard D. Francis | President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2024 | 67,231 | 201,693 | - | - | Restricted Share Units | |
| Teva- Pharmaceutical Indus... | Richard D. Francis | President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2024 | 67,231 | 154,356 (0%) | 0% | - | Ordinary Shares | |
| Teva- Pharmaceutical Indus... | Richard D. Francis | President and CEO | Sale of securities on an exchange or to another person at price $ 13.34 per share. | 03 Mar 2024 | 31,061 | 123,295 (0%) | 0% | 13.3 | 414,270 | Ordinary Shares |
| Teva- Pharmaceutical Indus... | Francis Richard D. | President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2024 | 161,655 | 161,655 (0%) | 0% | - | Ordinary Shares | |
| Teva- Pharmaceutical Indus... | D. Richard Francis | President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2024 | 161,655 | 323,311 | - | - | Restricted Share Units | |
| Teva- Pharmaceutical Indus... | D. Richard Francis | President and CEO | Sale of securities on an exchange or to another person at price $ 13.15 per share. | 15 Feb 2024 | 74,530 | 87,125 (0%) | 0% | 13.2 | 980,174 | Ordinary Shares |
| Netsol Technologies, Inc. | Michael Francis Richard | Director | 31 Dec 2023 | 6,023 | 13,344 (0%) | 0% | 0 | Common Stock | ||
| Mettler-Toledo International | Richard Francis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Nov 2023 | 250 | 250 | - | - | Stock Option (right to buy) | |
| Mettler-Toledo International | Richard Francis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Nov 2023 | 49 | 553 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Air Transport Services Gro... | Richard Francis Corrado | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 20.78 per share. | 03 Apr 2023 | 61,000 | 244,222 (0%) | 0% | 20.8 | 1,267,580 | Common Stock |
| Air Transport Services Gro... | Richard Francis Corrado | Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 23.00 per share. | 03 Mar 2023 | 2,000 | 183,222 (0%) | 0% | 23 | 46,000 | Common Stock |
| Air Transport Services Gro... | Richard Francis Corrado | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 20.96 per share. | 27 Feb 2023 | 13,087 | 181,222 (0%) | 0% | 21.0 | 274,304 | Common Stock |
| Air Transport Services Gro... | Richard Francis Corrado | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.98 per share. | 31 Dec 2022 | 10,308 | 168,135 (0%) | 0% | 26.0 | 267,802 | Common Stock |
| Mettler-Toledo International | Richard Francis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Nov 2022 | 224 | 224 | - | - | Stock Option (right to buy) | |
| Mettler-Toledo International | Richard Francis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Nov 2022 | 41 | 504 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Air Transport Services Gro... | Richard Francis Corrado | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 33.84 per share. | 25 Mar 2022 | 13,000 | 178,443 (0%) | 0% | 33.8 | 439,920 | Common Stock |
| Air Transport Services Gro... | Richard Francis Corrado | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 31.51 per share. | 28 Feb 2022 | 6,053 | 165,443 (0%) | 0% | 31.5 | 190,730 | Common Stock |
| Mettler-Toledo International | Richard Francis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Nov 2021 | 222 | 222 | - | - | Stock Option (right to buy) | |
| Mettler-Toledo International | Richard Francis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Nov 2021 | 30 | 463 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Air Transport Services Gro... | Richard Francis Corrado | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 26.69 per share. | 01 Mar 2021 | 18,300 | 167,305 (0%) | 0% | 26.7 | 488,427 | Common Stock |
| Mettler-Toledo International | Richard Francis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Nov 2020 | 316 | 316 | - | - | Stock Option (right to buy) | |
| Mettler-Toledo International | Richard Francis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Nov 2020 | 41 | 433 (0%) | 0% | 0 | Common Stock, par value $0.01 per share |